We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+6.49%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$439M
AUM Growth
+$22.7M
Cap. Flow
+$1.23M
Cap. Flow %
0.28%
Top 10 Hldgs %
18.86%
Holding
332
New
121
Increased
28
Reduced
53
Closed
100

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.29M
2
AXP icon
American Express
AXP
+$7.22M
3
CVS icon
CVS Health
CVS
+$4.98M
4
DVN icon
Devon Energy
DVN
+$4.92M
5
AMP icon
Ameriprise Financial
AMP
+$4.87M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$8.18M
2
CB icon
Chubb
CB
+$7.62M
3
NSC icon
Norfolk Southern
NSC
+$7.16M
4
PSA icon
Public Storage
PSA
+$7.08M
5
CPB icon
Campbell Soup
CPB
+$6.99M

Sector Composition

Rank Sector Weight
1 Technology 16.64%
2 Financials 14.44%
3 Healthcare 13.99%
4 Industrials 11.57%
5 Energy 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHK
1
DELISTED
Chesapeake Energy Corporation
CHK
$9.37M 2.13%
1,593
-1
-0.1% -$5.45K
TAP icon
2
Molson Coors Class B
TAP
$7.79B
$8.98M 2.05%
121,155
+60,400
+99% +$3.89M
CVS icon
3
CVS Health
CVS
$133B
$8.67M 1.98%
115,075
+65,905
+134% +$4.98M
TSN icon
4
Tyson Foods
TSN
$20.4B
$8.51M 1.94%
226,760
-15,575
-6% -$624K
CFN
5
DELISTED
CAREFUSION CORPORATION
CFN
$8.38M 1.91%
189,065
+112,165
+146% +$4.64M
UNP icon
6
Union Pacific
UNP
$174B
$8.04M 1.83%
80,625
+3,265
+4% +$316K
NE
7
DELISTED
Noble Corporation
NE
$8.02M 1.83%
273,204
+126,412
+86% +$3.47M
GILD icon
8
Gilead Sciences
GILD
$162B
$7.76M 1.77%
+93,610
New +$7.29M
AXP icon
9
American Express
AXP
$227B
$7.6M 1.73%
+80,125
New +$7.22M
GEN icon
10
Gen Digital
GEN
$16.4B
$7.49M 1.71%
327,170
+155,120
+90% +$3.3M
ORCL icon
11
Oracle
ORCL
$374B
$6.83M 1.56%
168,525
+81,425
+93% +$3.35M
BSX icon
12
Boston Scientific
BSX
$69.5B
$6.79M 1.55%
531,460
-60
-0% -$780
WDC icon
13
Western Digital
WDC
$188B
$6.58M 1.5%
94,284
+3,394
+4% +$227K
HPQ icon
14
HP
HPQ
$24.9B
$6.35M 1.45%
415,286
-221,114
-35% -$3.32M
LUMN icon
15
Lumen
LUMN
$6.57B
$5.75M 1.31%
158,880
– –
TRN icon
16
Trinity Industries
TRN
$2.49B
$5.74M 1.31%
182,278
+8,750
+5% +$248K
COR icon
17
Cencora
COR
$60.6B
$5.44M 1.24%
74,900
+6,165
+9% +$422K
DVN icon
18
Devon Energy
DVN
$52.1B
$5.37M 1.22%
+67,605
New +$4.92M
AET
19
DELISTED
Aetna Inc
AET
$5.31M 1.21%
65,440
– –
AMP icon
20
Ameriprise Financial
AMP
$48.3B
$5.22M 1.19%
+43,505
New +$4.87M
EOG icon
21
EOG Resources
EOG
$79.2B
$5.2M 1.18%
44,510
-3,150
-7% -$331K
XRX icon
22
Xerox
XRX
$387M
$5.02M 1.14%
153,062
-837
-0.5% -$26.6K
ADT
23
DELISTED
ADT Corp
ADT
$4.95M 1.13%
+141,530
New +$4.54M
DIS icon
24
Walt Disney
DIS
$167B
$4.93M 1.12%
57,470
-43,300
-43% -$3.54M
MSFT icon
25
Microsoft
MSFT
$3.45T
$4.88M 1.11%
117,050
-1,350
-1% -$54.6K
1
2 3 4 5

Similar funds

TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
VCM
Viewpoint Capital Management Seattle, Washington $214M AUM 28.5% 1-Year Est. Return
IH
IES Holdings Houston, Texas $214M AUM
CCM
Conway Capital Management Burbank, California $214M AUM 22.99% 1-Year Est. Return
SIA
Serenity Investment Advisors Chicago, Illinois $214M AUM
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
RSC
Rising Stella Capital Singapore $214M AUM

C.M. Bidwell & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, C.M. Bidwell & Associates held 332 positions worth $439M, up 5.5% from $416M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

C.M. Bidwell & Associates's Q2 2014 filing shows 121 new, 28 increased, 53 reduced and 100 closed positions. Its largest new stake was Gilead Sciences: 93,610 shares worth $7.76M. The largest sale was Charles Schwab, an estimated $8.18M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • C.M. Bidwell & Associates's largest Q2 2014 buy was Gilead Sciences: 93,610 shares worth $7.76M.
  • C.M. Bidwell & Associates added most to CVS Health in Q2 2014, an estimated $4.98M increase.
  • C.M. Bidwell & Associates's biggest Q2 2014 reduction was Chubb, cutting an estimated $7.62M.
  • C.M. Bidwell & Associates fully exited Charles Schwab in Q2 2014, selling an estimated $8.18M.
  • C.M. Bidwell & Associates's ten largest holdings make up 19% of its $439M portfolio in Q2 2014.
  • C.M. Bidwell & Associates opened 121 new positions and closed 100 in Q2 2014.
  • C.M. Bidwell & Associates's portfolio value rose 5.5% quarter-over-quarter to $439M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2014, filed 12 Aug 2014.